Refocused NetScientific Set For New Cash Injection To Boost Portfolio Investments
This article was originally published in Clinica
Executive Summary
AIM-listed NetScientific could see by the end of this week an additional £20m in its coffers, funds that will be used to take the healthcare tech investor’s most promising portfolio companies to commercialization and potential exits.